4//SEC Filing
Hashim Mir 4
Accession 0001209191-22-021018
CIK 0001856725other
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 9:06 PM ET
Size
7.2 KB
Accession
0001209191-22-021018
Insider Transaction Report
Form 4
Hashim Mir
Chief Scientific Officer
Transactions
- Award
Class A Common Stock
2022-03-22+41,200→ 158,800 total - Award
Stock Option (Right to Buy)
2022-03-22+125,400→ 125,400 totalExercise: $13.21Exp: 2032-03-21→ Class A Common Stock (125,400 underlying)
Footnotes (2)
- [F1]The shares subject to the restricted stock unit grant vest as follows: 25% of the RSUs shall vest yearly over four years from March 22, 2022.
- [F2]The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 22, 2022.
Documents
Issuer
Rani Therapeutics Holdings, Inc.
CIK 0001856725
Entity typeother
Related Parties
1- filerCIK 0001875891
Filing Metadata
- Form type
- 4
- Filed
- Mar 23, 8:00 PM ET
- Accepted
- Mar 24, 9:06 PM ET
- Size
- 7.2 KB